---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035196"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2026-07-29T20:21:44+00:00"
generated_at: "2026-07-29T20:23:22.678633+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# MiMedx to acquire Sanara MedTech for $35/share in cash and stock, ~$350M enterprise value

## Summary
- Sanara shareholders to receive $33 cash plus 0.4735 MiMedx shares per share, valued at $35 total.
- Total enterprise value approximately $350 million; transaction expected to close by July 2027.
- Over $20 million in anticipated annual run-rate cost synergies post-close.
- Stockholders holding ~38.9% of Sanara shares have agreed to vote in favor of the merger.
- Sanara will become a wholly-owned subsidiary of MiMedx; Sanara stock to be delisted from Nasdaq.

## SEC filing metadata
- accession: 0001493152-26-035196
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2026-07-29T20:21:44+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/0001493152-26-035196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035196
- JSON: https://secwatch.observer/filing/0001493152-26-035196.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.